Literature DB >> 21306919

Advanced chronic obstructive pulmonary disease is associated with high levels of high-density lipoprotein cholesterol.

Robert M Reed1, Aldo Iacono, Andrew DeFilippis, Michael Eberlein, Reda E Girgis, Steven Jones.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an inflammatory systemic disease associated with numerous extrapulmonary manifestations. Amongst these is an increased risk for cardiovascular disease. The mechanisms for this association remain unclear. We sought to examine lipid trends in a well-characterized cohort of patients with severe COPD.
METHODS: We conducted a retrospective prospective analysis of 126 consecutive individuals evaluated for lung transplantation with a diagnosis of COPD in whom lipid values were available. Observed lipid values were compared with a reference population without severe COPD.
RESULTS: Compared with the reference population, mean low-density lipoprotein cholesterol (LDL-C) levels were slightly reduced at 108 ± 44 vs 117 ± 29.5 mg/dl (p = 0.02) in men but were no different in women. Mean high-density lipoprotein cholesterol (HDL-C) levels were significantly elevated at 62 ± 24 vs 45 ± 12 mg/dl (p < 0.0001) in men and at 83 ± 27 vs 59 ± 16 mg/dl in women (p < 0.0001). Prednisone use correlated with higher HDL-C levels but did not fully explain the extent of elevation. Angiographically proven coronary artery disease was found in 61% of individuals and was unrelated to HDL-C levels.
CONCLUSIONS: Severe COPD is associated with increased levels of HDL-C, which is partially attributable to oral steroid use. HDL-C in this population is not associated with reduced risk of angiographically proven coronary artery disease.
Copyright © 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21306919     DOI: 10.1016/j.healun.2010.12.010

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  13 in total

Review 1.  What model organisms and interactomics can reveal about the genetics of human obesity.

Authors:  Michael J Williams; Markus S Almén; Robert Fredriksson; Helgi B Schiöth
Journal:  Cell Mol Life Sci       Date:  2012-05-23       Impact factor: 9.261

2.  Genetic variations in RORα are associated with chronic obstructive pulmonary disease.

Authors:  Yiming Yuan; Xiaoming Hou; Jinlong Zhang; Yulong Chen; Yulin Feng; Zhiguang Su
Journal:  J Hum Genet       Date:  2014-06-19       Impact factor: 3.172

3.  Coronary artery disease is under-diagnosed and under-treated in advanced lung disease.

Authors:  Robert M Reed; Michael Eberlein; Reda E Girgis; Salman Hashmi; Aldo Iacono; Steven Jones; Giora Netzer; Steven Scharf
Journal:  Am J Med       Date:  2012-09-06       Impact factor: 4.965

4.  APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema.

Authors:  Kristin M Burkart; Ani Manichaikul; Jemma B Wilk; Firas S Ahmed; Gregory L Burke; Paul Enright; Nadia N Hansel; Demondes Haynes; Susan R Heckbert; Eric A Hoffman; Joel D Kaufman; Jun Kurai; Laura Loehr; Stephanie J London; Yang Meng; George T O'Connor; Elizabeth Oelsner; Marcy Petrini; Tess D Pottinger; Charles A Powell; Susan Redline; Jerome I Rotter; Lewis J Smith; María Soler Artigas; Martin D Tobin; Michael Y Tsai; Karol Watson; Wendy White; Taylor R Young; Stephen S Rich; R Graham Barr
Journal:  Eur Respir J       Date:  2013-07-30       Impact factor: 16.671

5.  Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007-2010.

Authors:  Earl S Ford; Anne G Wheaton; David M Mannino; Letitia Presley-Cantrell; Chaoyang Li; Janet B Croft
Journal:  Respir Res       Date:  2012-12-13

6.  The Effect of Statins on Blood Gene Expression in COPD.

Authors:  Ma'en Obeidat; Nick Fishbane; Yunlong Nie; Virginia Chen; Zsuzsanna Hollander; Scott J Tebbutt; Yohan Bossé; Raymond T Ng; Bruce E Miller; Bruce McManus; Stephen Rennard; Peter D Paré; Don D Sin
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

7.  Association between high-density lipoprotein cholesterol level and pulmonary function in healthy Korean adolescents: the JS high school study.

Authors:  Ji Hye Park; Seyeon Mun; Dong Phil Choi; Joo Young Lee; Hyeon Chang Kim
Journal:  BMC Pulm Med       Date:  2017-12-11       Impact factor: 3.317

8.  Tobacco Smoke Exposure Reduces Paraoxonase Activity in a Murine Model.

Authors:  Robert M Reed; Saif M Borgan; Michael Eberlein; Monica Goldklang; Joshua Lewis; Michael Miller; Mohamad Navab; Bo S Kim
Journal:  Int J Biomed Sci       Date:  2017-03

9.  The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease.

Authors:  Beti Zafirova-Ivanovska; Jagoda Stojkovikj; Dejan Dokikj; Sasha Anastasova; Angela Debresliovska; Sead Zejnel; Dragana Stojkovikj
Journal:  Open Access Maced J Med Sci       Date:  2016-05-24

10.  Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.

Authors:  Ding Liu; Maureen Meister; Shiying Zhang; Chi-In Vong; Shuaishuai Wang; Ruixie Fang; Lei Li; Peng George Wang; Pierre Massion; Xiangming Ji
Journal:  Respir Res       Date:  2020-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.